Template:BV Antibiotics - Revision history

Danbot: Strip translate tags to enable SMW subobject creation

2026-03-20T02:54:13Z

Strip translate tags to enable SMW subobject creation

← Revisión anterior		Revisión del 02:54 20 mar 2026
Línea 1:		Línea 1:
	~~<noinclude><languages/></noinclude>~~
	~~<translate>~~
	====First Line Therapy<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>====		====First Line Therapy<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>====
	~~<!--T:1-->~~

	~~<!--T:2-->~~
	*{{AntibioticDose\|disease=Bacterial vaginosis\|drug=Metronidazole\|dose=500 mg PO Twice Daily for 7 days\|context=First Line}} OR		*{{AntibioticDose\|disease=Bacterial vaginosis\|drug=Metronidazole\|dose=500 mg PO Twice Daily for 7 days\|context=First Line}} OR
	*[[Metronidazole]] gel 0.75%, one full applicator (5 g) intravaginally, Daily for 5 days OR		*[[Metronidazole]] gel 0.75%, one full applicator (5 g) intravaginally, Daily for 5 days OR
Línea 11:		Línea 6:

	====Alternative Regimin====		====Alternative Regimin====
	~~<!--T:3-->~~

	~~<!--T:4-->~~
	*{{AntibioticDose\|disease=Bacterial vaginosis\|drug=Clindamycin\|dose=300 mg PO BID for 7 days\|context=Alternative}} OR		*{{AntibioticDose\|disease=Bacterial vaginosis\|drug=Clindamycin\|dose=300 mg PO BID for 7 days\|context=Alternative}} OR
	*[[Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 hours)		*[[Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 hours)
Línea 19:		Línea 11:

	====Pregnant====		====Pregnant====
	~~<!--T:5-->~~

	~~<!--T:6-->~~
	*{{AntibioticDose\|disease=Bacterial vaginosis\|drug=Metronidazole\|dose=500mg PO Twice a day x 7 days\|context=Pregnant}}<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>		*{{AntibioticDose\|disease=Bacterial vaginosis\|drug=Metronidazole\|dose=500mg PO Twice a day x 7 days\|context=Pregnant}}<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>
	*[[Metronidazole]] 250mg PO Three times a day has also been studied<ref name="Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis">Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis[http://www.ncbi.nlm.nih.gov/pubmed/7491136]</ref><ref name="Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study">Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study[http://www.ncbi.nlm.nih.gov/pubmed/8059811]</ref>		*[[Metronidazole]] 250mg PO Three times a day has also been studied<ref name="Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis">Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis[http://www.ncbi.nlm.nih.gov/pubmed/7491136]</ref><ref name="Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study">Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study[http://www.ncbi.nlm.nih.gov/pubmed/8059811]</ref>
	* Although metronidazole crosses the placenta, no evidence of teratogenicity or mutagenic effects among infants has been reported in multiple cross-sectional, case-control, and cohort studies of pregnant women<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>		* Although metronidazole crosses the placenta, no evidence of teratogenicity or mutagenic effects among infants has been reported in multiple cross-sectional, case-control, and cohort studies of pregnant women<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>

	====Prophylaxis ([[~~Special:MyLanguage/~~Sexual Assault\|Sexual Assault]])====		====Prophylaxis ([[Sexual Assault\|Sexual Assault]])====
	~~<!--T:7-->~~

	~~<!--T:8-->~~
	*{{AntibioticDose\|disease=Bacterial vaginosis\|drug=Metronidazole\|dose=500mg PO Twice a day x 7 days\|context=Sexual Assault Prophylaxis}}<ref name="Sexual Assault and Abuse and STIs – Adolescents and Adults">Sexual Assault and Abuse and STIs – Adolescents and Adults[https://www.cdc.gov/std/treatment-guidelines/sexual-assault-adults.htm]</ref>		*{{AntibioticDose\|disease=Bacterial vaginosis\|drug=Metronidazole\|dose=500mg PO Twice a day x 7 days\|context=Sexual Assault Prophylaxis}}<ref name="Sexual Assault and Abuse and STIs – Adolescents and Adults">Sexual Assault and Abuse and STIs – Adolescents and Adults[https://www.cdc.gov/std/treatment-guidelines/sexual-assault-adults.htm]</ref>
	~~</translate>~~

Danbot: Convert to AntibioticDose with disease=Bacterial vaginosis

2026-03-19T23:39:18Z

Convert to AntibioticDose with disease=Bacterial vaginosis

← Revisión anterior		Revisión del 23:39 19 mar 2026
Línea 1:		Línea 1:
	<noinclude><languages/></noinclude>		<noinclude><languages/></noinclude>
	<translate>		<translate>
			====First Line Therapy<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>====
	====First Line Therapy<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>==== <!--T:1-->		<!--T:1-->

	<!--T:2-->		<!--T:2-->
	*~~[[Special:MyLanguage/~~Metronidazole\|~~Metronidazole]]~~ 500 mg PO Twice Daily for 7 days OR		*{{AntibioticDose\|disease=Bacterial vaginosis\|drug=Metronidazole\|dose=500 mg PO Twice Daily for 7 days\|context=First Line}} OR
	*[[~~Special:MyLanguage/Metronidazole\|~~Metronidazole]] gel 0.75%, one full applicator (5 g) intravaginally, Daily for 5 days OR		*[[Metronidazole]] gel 0.75%, one full applicator (5 g) intravaginally, Daily for 5 days OR
	*~~[[Special:MyLanguage/~~Clindamycin\|~~Clindamycin]]~~ cream 2%, one full applicator (5 g) intravaginally Nightly for 7 days		*{{AntibioticDose\|disease=Bacterial vaginosis\|drug=Clindamycin\|dose=cream 2%, one full applicator (5 g) intravaginally Nightly for 7 days\|context=First Line, Topical}}
	Metronidazole does not cause a disulfiram-like reaction with alcohol.<ref name="Is combining metronidazole and alcohol really hazardous?">Is combining metronidazole and alcohol really hazardous?[http://www.ncbi.nlm.nih.gov/pubmed/25223673]</ref>		Metronidazole does not cause a disulfiram-like reaction with alcohol.<ref name="Is combining metronidazole and alcohol really hazardous?">Is combining metronidazole and alcohol really hazardous?[http://www.ncbi.nlm.nih.gov/pubmed/25223673]</ref>

			====Alternative Regimin====
	====Alternative Regimin==== <!--T:3-->		<!--T:3-->

	<!--T:4-->		<!--T:4-->
	*~~[[Special:MyLanguage/~~Clindamycin\|~~Clindamycin]]~~ 300 mg PO BID for 7 days OR		*{{AntibioticDose\|disease=Bacterial vaginosis\|drug=Clindamycin\|dose=300 mg PO BID for 7 days\|context=Alternative}} OR
	*[[~~Special:MyLanguage/Clindamycin\|~~Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 hours)		*[[Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 hours)
	Other regimens have been studied and have varying efficacy compared to placebo but due to cost and availability do not represent alternatives outside of absolute contraindications to preferred regimens.		Other regimens have been studied and have varying efficacy compared to placebo but due to cost and availability do not represent alternatives outside of absolute contraindications to preferred regimens.

			====Pregnant====
			<!--T:5-->

	====Pregnant==== <!--T:5-->

	<!--T:6-->		<!--T:6-->
	*~~[[Special:MyLanguage/~~Metronidazole\|~~Metronidazole]]~~ 500mg PO Twice a day x 7 days<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>		*{{AntibioticDose\|disease=Bacterial vaginosis\|drug=Metronidazole\|dose=500mg PO Twice a day x 7 days\|context=Pregnant}}<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>
	*[[~~Special:MyLanguage/Metronidazole\|~~Metronidazole]] 250mg PO Three times a day has also been studied<ref name="Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis">Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis[http://www.ncbi.nlm.nih.gov/pubmed/7491136]</ref><ref name="Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study">Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study[http://www.ncbi.nlm.nih.gov/pubmed/8059811]</ref>		*[[Metronidazole]] 250mg PO Three times a day has also been studied<ref name="Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis">Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis[http://www.ncbi.nlm.nih.gov/pubmed/7491136]</ref><ref name="Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study">Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study[http://www.ncbi.nlm.nih.gov/pubmed/8059811]</ref>
	* Although metronidazole crosses the placenta, no evidence of teratogenicity or mutagenic effects among infants has been reported in multiple cross-sectional, case-control, and cohort studies of pregnant women<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>		* Although metronidazole crosses the placenta, no evidence of teratogenicity or mutagenic effects among infants has been reported in multiple cross-sectional, case-control, and cohort studies of pregnant women<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>

			====Prophylaxis ([[Special:MyLanguage/Sexual Assault\|Sexual Assault]])====
	====Prophylaxis ([[Special:MyLanguage/Sexual Assault\|Sexual Assault]])==== <!--T:7-->		<!--T:7-->

	<!--T:8-->		<!--T:8-->
	*~~[[Special:MyLanguage/~~Metronidazole\|~~Metronidazole]]~~ 500mg PO Twice a day x 7 days<ref name="Sexual Assault and Abuse and STIs – Adolescents and Adults">Sexual Assault and Abuse and STIs – Adolescents and Adults[https://www.cdc.gov/std/treatment-guidelines/sexual-assault-adults.htm]</ref>		*{{AntibioticDose\|disease=Bacterial vaginosis\|drug=Metronidazole\|dose=500mg PO Twice a day x 7 days\|context=Sexual Assault Prophylaxis}}<ref name="Sexual Assault and Abuse and STIs – Adolescents and Adults">Sexual Assault and Abuse and STIs – Adolescents and Adults[https://www.cdc.gov/std/treatment-guidelines/sexual-assault-adults.htm]</ref>
	</translate>		</translate>

Ostermayer: Marked this version for translation

2026-01-26T01:20:13Z

Marked this version for translation

← Revisión anterior		Revisión del 01:20 26 ene 2026
Línea 2:		Línea 2:
	<translate>		<translate>

	====First Line Therapy<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>====		====First Line Therapy<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>==== <!--T:1-->

			<!--T:2-->
	*[[Special:MyLanguage/Metronidazole\|Metronidazole]] 500 mg PO Twice Daily for 7 days OR		*[[Special:MyLanguage/Metronidazole\|Metronidazole]] 500 mg PO Twice Daily for 7 days OR
	*[[Special:MyLanguage/Metronidazole\|Metronidazole]] gel 0.75%, one full applicator (5 g) intravaginally, Daily for 5 days OR		*[[Special:MyLanguage/Metronidazole\|Metronidazole]] gel 0.75%, one full applicator (5 g) intravaginally, Daily for 5 days OR
Línea 10:		Línea 11:


	====Alternative Regimin====		====Alternative Regimin==== <!--T:3-->

			<!--T:4-->
	*[[Special:MyLanguage/Clindamycin\|Clindamycin]] 300 mg PO BID for 7 days OR		*[[Special:MyLanguage/Clindamycin\|Clindamycin]] 300 mg PO BID for 7 days OR
	*[[Special:MyLanguage/Clindamycin\|Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 hours)		*[[Special:MyLanguage/Clindamycin\|Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 hours)
Línea 19:		Línea 21:


	====Pregnant====		====Pregnant==== <!--T:5-->

			<!--T:6-->
	*[[Special:MyLanguage/Metronidazole\|Metronidazole]] 500mg PO Twice a day x 7 days<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>		*[[Special:MyLanguage/Metronidazole\|Metronidazole]] 500mg PO Twice a day x 7 days<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>
	*[[Special:MyLanguage/Metronidazole\|Metronidazole]] 250mg PO Three times a day has also been studied<ref name="Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis">Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis[http://www.ncbi.nlm.nih.gov/pubmed/7491136]</ref><ref name="Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study">Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study[http://www.ncbi.nlm.nih.gov/pubmed/8059811]</ref>		*[[Special:MyLanguage/Metronidazole\|Metronidazole]] 250mg PO Three times a day has also been studied<ref name="Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis">Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis[http://www.ncbi.nlm.nih.gov/pubmed/7491136]</ref><ref name="Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study">Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study[http://www.ncbi.nlm.nih.gov/pubmed/8059811]</ref>
Línea 26:		Línea 29:


	====Prophylaxis ([[Special:MyLanguage/Sexual Assault\|Sexual Assault]])====		====Prophylaxis ([[Special:MyLanguage/Sexual Assault\|Sexual Assault]])==== <!--T:7-->

			<!--T:8-->
	*[[Special:MyLanguage/Metronidazole\|Metronidazole]] 500mg PO Twice a day x 7 days<ref name="Sexual Assault and Abuse and STIs – Adolescents and Adults">Sexual Assault and Abuse and STIs – Adolescents and Adults[https://www.cdc.gov/std/treatment-guidelines/sexual-assault-adults.htm]</ref>		*[[Special:MyLanguage/Metronidazole\|Metronidazole]] 500mg PO Twice a day x 7 days<ref name="Sexual Assault and Abuse and STIs – Adolescents and Adults">Sexual Assault and Abuse and STIs – Adolescents and Adults[https://www.cdc.gov/std/treatment-guidelines/sexual-assault-adults.htm]</ref>
	</translate>		</translate>

Ostermayer at 01:20, 26 January 2026

2026-01-26T01:20:06Z

← Revisión anterior		Revisión del 01:20 26 ene 2026
Línea 1:		Línea 1:
	<languages/>		<noinclude><languages/></noinclude>
	<translate>		<translate>

Ostermayer: Prepared the page for translation

2026-01-26T01:19:48Z

Prepared the page for translation

← Revisión anterior		Revisión del 01:19 26 ene 2026
Línea 1:		Línea 1:
			<languages/>
			<translate>

	====First Line Therapy<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>====		====First Line Therapy<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>====
	*[[Metronidazole]] 500 mg PO Twice Daily for 7 days OR
	*[[Metronidazole]] gel 0.75%, one full applicator (5 g) intravaginally, Daily for 5 days OR		*[[Special:MyLanguage/Metronidazole\|Metronidazole]] 500 mg PO Twice Daily for 7 days OR
	*[[Clindamycin]] cream 2%, one full applicator (5 g) intravaginally Nightly for 7 days		*[[Special:MyLanguage/Metronidazole\|Metronidazole]] gel 0.75%, one full applicator (5 g) intravaginally, Daily for 5 days OR
			*[[Special:MyLanguage/Clindamycin\|Clindamycin]] cream 2%, one full applicator (5 g) intravaginally Nightly for 7 days
	Metronidazole does not cause a disulfiram-like reaction with alcohol.<ref name="Is combining metronidazole and alcohol really hazardous?">Is combining metronidazole and alcohol really hazardous?[http://www.ncbi.nlm.nih.gov/pubmed/25223673]</ref>		Metronidazole does not cause a disulfiram-like reaction with alcohol.<ref name="Is combining metronidazole and alcohol really hazardous?">Is combining metronidazole and alcohol really hazardous?[http://www.ncbi.nlm.nih.gov/pubmed/25223673]</ref>


	====Alternative Regimin====		====Alternative Regimin====
	*[[Clindamycin]] 300 mg PO BID for 7 days OR
	*[[Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 hours)		*[[Special:MyLanguage/Clindamycin\|Clindamycin]] 300 mg PO BID for 7 days OR
			*[[Special:MyLanguage/Clindamycin\|Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 hours)
	Other regimens have been studied and have varying efficacy compared to placebo but due to cost and availability do not represent alternatives outside of absolute contraindications to preferred regimens.		Other regimens have been studied and have varying efficacy compared to placebo but due to cost and availability do not represent alternatives outside of absolute contraindications to preferred regimens.




	====Pregnant====		====Pregnant====
	*[[Metronidazole]] 500mg PO Twice a day x 7 days<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>
	*[[Metronidazole]] 250mg PO Three times a day has also been studied<ref name="Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis">Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis[http://www.ncbi.nlm.nih.gov/pubmed/7491136]</ref><ref name="Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study">Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study[http://www.ncbi.nlm.nih.gov/pubmed/8059811]</ref>		*[[Special:MyLanguage/Metronidazole\|Metronidazole]] 500mg PO Twice a day x 7 days<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>
			*[[Special:MyLanguage/Metronidazole\|Metronidazole]] 250mg PO Three times a day has also been studied<ref name="Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis">Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis[http://www.ncbi.nlm.nih.gov/pubmed/7491136]</ref><ref name="Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study">Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study[http://www.ncbi.nlm.nih.gov/pubmed/8059811]</ref>
	* Although metronidazole crosses the placenta, no evidence of teratogenicity or mutagenic effects among infants has been reported in multiple cross-sectional, case-control, and cohort studies of pregnant women<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>		* Although metronidazole crosses the placenta, no evidence of teratogenicity or mutagenic effects among infants has been reported in multiple cross-sectional, case-control, and cohort studies of pregnant women<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>

	====Prophylaxis ([[Sexual Assault]])====
	*[[Metronidazole]] 500mg PO Twice a day x 7 days<ref name="Sexual Assault and Abuse and STIs – Adolescents and Adults">Sexual Assault and Abuse and STIs – Adolescents and Adults[https://www.cdc.gov/std/treatment-guidelines/sexual-assault-adults.htm]</ref>		====Prophylaxis ([[Special:MyLanguage/Sexual Assault\|Sexual Assault]])====

			*[[Special:MyLanguage/Metronidazole\|Metronidazole]] 500mg PO Twice a day x 7 days<ref name="Sexual Assault and Abuse and STIs – Adolescents and Adults">Sexual Assault and Abuse and STIs – Adolescents and Adults[https://www.cdc.gov/std/treatment-guidelines/sexual-assault-adults.htm]</ref>
			</translate>

Kpharmer: /* Pregnant */

2025-10-01T20:05:47Z

Pregnant

← Revisión anterior		Revisión del 20:05 1 oct 2025
Línea 1:		Línea 1:
	====First Line Therapy<ref>~~Workoski KA and Bolan GA.~~ Sexually ~~transmitted diseases treatment guidelines~~, ~~2015~~. ~~MMWR Recommen and Reports~~. ~~2015; 64(3):1~~-~~140~~.</ref>====		====First Line Therapy<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>====
	*[[Metronidazole]] 500 mg PO ~~BID~~ for 7 days OR		*[[Metronidazole]] 500 mg PO Twice Daily for 7 days OR
	*[[Metronidazole]] gel 0.75%, one full applicator (5 g) intravaginally, qd for 5 days OR		*[[Metronidazole]] gel 0.75%, one full applicator (5 g) intravaginally, Daily for 5 days OR
	*[[Clindamycin]] cream 2%, one full applicator (5 g) intravaginally ~~qHS~~ for 7 days		*[[Clindamycin]] cream 2%, one full applicator (5 g) intravaginally Nightly for 7 days
			Metronidazole does not cause a disulfiram-like reaction with alcohol.<ref name="Is combining metronidazole and alcohol really hazardous?">Is combining metronidazole and alcohol really hazardous?[http://www.ncbi.nlm.nih.gov/pubmed/25223673]</ref>

	====Alternative Regimin====		====Alternative Regimin====
	*[[Tinidazole]] 2 g PO qd for 2 days OR
	*[[Tinidazole]] 1 g PO qd for 5 days OR
	*[[Clindamycin]] 300 mg PO BID for 7 days OR		*[[Clindamycin]] 300 mg PO BID for 7 days OR
	*[[Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 ~~hrs~~)		*[[Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 hours)
			Other regimens have been studied and have varying efficacy compared to placebo but due to cost and availability do not represent alternatives outside of absolute contraindications to preferred regimens.



	====Pregnant====		====Pregnant====
	*[[Metronidazole]] ~~250mg~~ PO ~~q8h~~ x 7 days<ref name="~~cdc~~">CDC ~~Pregnancy BV~~ Treatment Guidelines.[~~http~~://www.cdc.gov/~~std~~/~~treatment~~/~~2010~~/~~vaginal~~-~~discharge.htm#a1 cdc~~.~~gov~~]</ref>		*[[Metronidazole]] 500mg PO Twice a day x 7 days<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>
	*[[Metronidazole]] 2g PO ~~x 1 dose is~~ also ~~acceptable~~<ref name="~~cdc~~" />		*[[Metronidazole]] 250mg PO Three times a day has also been studied<ref name="Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis">Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis[http://www.ncbi.nlm.nih.gov/pubmed/7491136]</ref><ref name="Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study">Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study[http://www.ncbi.nlm.nih.gov/pubmed/8059811]</ref>
	* ~~Multiple~~ studies ~~have not demonstrated teratogenicity from metronidazole use~~<ref name="cdc" />		* Although metronidazole crosses the placenta, no evidence of teratogenicity or mutagenic effects among infants has been reported in multiple cross-sectional, case-control, and cohort studies of pregnant women<ref name="CDC Sexually Transmitted Infections Treatment Guidelines, 2021">CDC Sexually Transmitted Infections Treatment Guidelines, 2021.[https://www.cdc.gov/mmwr/volumes/70/rr/pdfs/rr7004a1-H.pdf]</ref>

	====Prophylaxis ([[Sexual Assault]])====		====Prophylaxis ([[Sexual Assault]])====
	*[[Metronidazole]] ~~2 g~~ PO x ~~1 OR~~		*[[Metronidazole]] 500mg PO Twice a day x 7 days<ref name="Sexual Assault and Abuse and STIs – Adolescents and Adults">Sexual Assault and Abuse and STIs – Adolescents and Adults[https://www.cdc.gov/std/treatment-guidelines/sexual-assault-adults.htm]</ref>
	*[~~[Tinidazole]~~] ~~2 g PO x 1~~

Mholtz at 04:27, 18 August 2015

2015-08-18T04:27:14Z

← Revisión anterior		Revisión del 04:27 18 ago 2015
Línea 4:		Línea 4:
	*[[Clindamycin]] cream 2%, one full applicator (5 g) intravaginally qHS for 7 days		*[[Clindamycin]] cream 2%, one full applicator (5 g) intravaginally qHS for 7 days

	====Alternative ~~Regimine~~====		====Alternative Regimin====
	*[[Tinidazole]] 2 g PO qd for 2 days OR		*[[Tinidazole]] 2 g PO qd for 2 days OR
	*[[Tinidazole]] 1 g PO qd for 5 days OR		*[[Tinidazole]] 1 g PO qd for 5 days OR
Línea 10:		Línea 10:
	*[[Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 hrs)		*[[Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 hrs)

	====~~Pregnancy~~====		====Pregnant====
	*~~Alternative:~~ 250mg PO q8h x 7 days ~~in pregnant patients~~<ref name="cdc">CDC Pregnancy BV Treatment Guidelines.[http://www.cdc.gov/std/treatment/2010/vaginal-discharge.htm#a1 cdc.gov]</ref>		*[[Metronidazole]] 250mg PO q8h x 7 days<ref name="cdc">CDC Pregnancy BV Treatment Guidelines.[http://www.cdc.gov/std/treatment/2010/vaginal-discharge.htm#a1 cdc.gov]</ref>
	*2g PO x 1 is also acceptable ~~in pregnancy~~<ref name="cdc"></~~ref~~>		*[[Metronidazole]] 2g PO x 1 dose is also acceptable<ref name="cdc" />
	* Multiple studies have not demonstrated teratogenicity from metronidazole use<ref name="cdc"></~~ref~~>		* Multiple studies have not demonstrated teratogenicity from metronidazole use<ref name="cdc" />

	====Prophylaxis ([[Sexual Assault]])====		====Prophylaxis ([[Sexual Assault]])====
	*[[Metronidazole]] 2 g PO x 1 OR		*[[Metronidazole]] 2 g PO x 1 OR
	*[[Tinidazole]] 2 g PO x 1		*[[Tinidazole]] 2 g PO x 1

Neil.m.young: updated treatment per CDC

2015-06-05T14:47:51Z

updated treatment per CDC

← Revisión anterior		Revisión del 14:47 5 jun 2015
Línea 1:		Línea 1:
	*[[Metronidazole]] 2g PO ~~once~~		====First Line Therapy<ref>Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.</ref>====
	**~~Adolescent '''<45kg:''' 15 mg/kg/day~~ PO ~~divided q8h x 7~~ days OR ~~7mg/kg PO x 1~~		*[[Metronidazole]] 500 mg PO BID for 7 days OR
	**Adolescent '''>45kg:'''2g PO ~~x 1~~		*[[Metronidazole]] gel 0.75%, one full applicator (5 g) intravaginally, qd for 5 days OR
	*[[Clindamycin]] ~~300mg~~ PO BID x 7 days		*[[Clindamycin]] cream 2%, one full applicator (5 g) intravaginally qHS for 7 days

			====Alternative Regimine====
			*[[Tinidazole]] 2 g PO qd for 2 days OR
			*[[Tinidazole]] 1 g PO qd for 5 days OR
			*[[Clindamycin]] 300 mg PO BID for 7 days OR
			*[[Clindamycin]] ovules 100 mg intravaginally qHS for 3 days (do not use if patient has used latex condom in last 72 hrs)

	====Pregnancy====		====Pregnancy====
Línea 11:		Línea 17:
	====Prophylaxis ([[Sexual Assault]])====		====Prophylaxis ([[Sexual Assault]])====
	*[[Metronidazole]] 2 g PO x 1 OR		*[[Metronidazole]] 2 g PO x 1 OR
	*[[~~Clindamycin~~]] ~~300mg~~ PO ~~BID~~ x ~~7 days~~		*[[Tinidazole]] 2 g PO x 1

Ostermayer at 19:52, 19 April 2015

2015-04-19T19:52:24Z

← Revisión anterior		Revisión del 19:52 19 abr 2015
Línea 1:		Línea 1:
	*[[Metronidazole]] 2g PO once		*[[Metronidazole]] 2g PO once
	**'''<45kg:''' 15 mg/kg/day PO divided q8h x 7 days OR 7mg/kg PO x 1		**Adolescent '''<45kg:''' 15 mg/kg/day PO divided q8h x 7 days OR 7mg/kg PO x 1
	**'''>45kg:'''2g PO x 1		**Adolescent '''>45kg:'''2g PO x 1
	*[[Clindamycin]] 300mg PO BID x 7 days		*[[Clindamycin]] 300mg PO BID x 7 days

Ostermayer: Created page with "Metronidazole 2g PO once '''<45kg:''' 15 mg/kg/day PO divided q8h x 7 days OR 7mg/kg PO x 1 '''>45kg:'''2g PO x 1 Clindamycin 300mg PO BID x 7 days ====Pregnanc..."

2015-04-19T19:51:35Z

Created page with "*Metronidazole 2g PO once **'''<45kg:''' 15 mg/kg/day PO divided q8h x 7 days OR 7mg/kg PO x 1 **'''>45kg:'''2g PO x 1 *Clindamycin 300mg PO BID x 7 days ====Pregnanc..."

Página nueva

*[[Metronidazole]] 2g PO once
**'''<45kg:''' 15 mg/kg/day PO divided q8h x 7 days OR 7mg/kg PO x 1
**'''>45kg:'''2g PO x 1
*[[Clindamycin]] 300mg PO BID x 7 days

====Pregnancy====
*Alternative: 250mg PO q8h x 7 days in pregnant patients<ref name="cdc">CDC Pregnancy BV Treatment Guidelines.[http://www.cdc.gov/std/treatment/2010/vaginal-discharge.htm#a1 cdc.gov]</ref>
*2g PO x 1 is also acceptable in pregnancy<ref name="cdc"></ref>
* Multiple studies have not demonstrated teratogenicity from metronidazole use<ref name="cdc"></ref>

====Prophylaxis ([[Sexual Assault]])====
*[[Metronidazole]] 2 g PO x 1 OR
*[[Clindamycin]] 300mg PO BID x 7 days